<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd">
<html xmlns="http://www.w3.org/1999/xhtml" xml:lang="en" lang="en">
    
    <head><meta http-equiv="Content-Type" content="text/html; charset=utf-8" />
        <!-- AppResources meta begin -->
        <meta name="paf-app-resources" content="" />
                 <script type="text/javascript">var ncbi_startTime = new Date();</script>
            
        <!-- AppResources meta end -->
        
        <!-- TemplateResources meta begin -->
        <meta name="paf_template" content="" />

        <!-- TemplateResources meta end -->
        
        <!-- Logger begin -->
        <meta name="ncbi_db" content="books" /><meta name="ncbi_pdid" content="book-part" /><meta name="ncbi_acc" content="NBK84551" /><meta name="ncbi_domain" content="gene" /><meta name="ncbi_report" content="record" /><meta name="ncbi_type" content="fulltext" /><meta name="ncbi_objectid" content="" /><meta name="ncbi_pcid" content="/NBK84551/" /><meta name="ncbi_pagename" content="Systemic Primary Carnitine Deficiency - GeneReviews® - NCBI Bookshelf" /><meta name="ncbi_bookparttype" content="chapter" /><meta name="ncbi_app" content="bookshelf" />
        <!-- Logger end -->
        
        <title>Systemic Primary Carnitine Deficiency - GeneReviews® - NCBI Bookshelf</title>
        
        <!-- AppResources external_resources begin -->
        <link rel="stylesheet" href="/core/jig/1.14.8/css/jig.min.css" /><script type="text/javascript" src="/core/jig/1.14.8/js/jig.min.js"></script>

        <!-- AppResources external_resources end -->
        
        <!-- Page meta begin -->
        <meta name="robots" content="INDEX,FOLLOW,NOARCHIVE" /><meta name="citation_inbook_title" content="GeneReviews® [Internet]" /><meta name="citation_title" content="Systemic Primary Carnitine Deficiency" /><meta name="citation_publisher" content="University of Washington, Seattle" /><meta name="citation_date" content="2016/11/03" /><meta name="citation_author" content="Ayman W El-Hattab" /><meta name="citation_pmid" content="22420015" /><meta name="citation_fulltext_html_url" content="https://www.ncbi.nlm.nih.gov/books/NBK84551/" /><meta name="citation_keywords" content="Carnitine Transport Defect" /><meta name="citation_keywords" content="Carnitine Uptake Defect" /><meta name="citation_keywords" content="CDSP" /><meta name="citation_keywords" content="Carnitine Uptake Defect" /><meta name="citation_keywords" content="CDSP" /><meta name="citation_keywords" content="Carnitine Transport Defect" /><meta name="citation_keywords" content="Solute carrier family 22 member 5" /><meta name="citation_keywords" content="SLC22A5" /><meta name="citation_keywords" content="Systemic Primary Carnitine Deficiency" /><link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /><meta name="DC.Title" content="Systemic Primary Carnitine Deficiency" /><meta name="DC.Type" content="Text" /><meta name="DC.Publisher" content="University of Washington, Seattle" /><meta name="DC.Contributor" content="Ayman W El-Hattab" /><meta name="DC.Date" content="2016/11/03" /><meta name="DC.Identifier" content="https://www.ncbi.nlm.nih.gov/books/NBK84551/" /><meta name="description" content="Systemic primary carnitine deficiency (CDSP) is a disorder of the carnitine cycle that results in defective fatty acid oxidation. It encompasses a broad clinical spectrum including the following:" /><meta name="og:title" content="Systemic Primary Carnitine Deficiency" /><meta name="og:type" content="book" /><meta name="og:description" content="Systemic primary carnitine deficiency (CDSP) is a disorder of the carnitine cycle that results in defective fatty acid oxidation. It encompasses a broad clinical spectrum including the following:" /><meta name="og:url" content="https://www.ncbi.nlm.nih.gov/books/NBK84551/" /><meta name="og:site_name" content="NCBI Bookshelf" /><meta name="og:image" content="https://www.ncbi.nlm.nih.gov/corehtml/pmc/pmcgifs/bookshelf/thumbs/th-gene-lrg.png" /><meta name="twitter:card" content="summary" /><meta name="twitter:site" content="@ncbibooks" /><meta name="bk-non-canon-loc" content="/books/n/gene/cdsp/" /><link rel="canonical" href="https://www.ncbi.nlm.nih.gov/books/NBK84551/" /><link rel="stylesheet" href="/corehtml/pmc/css/figpopup.css" type="text/css" media="screen" /><link rel="stylesheet" href="/corehtml/pmc/css/bookshelf/2.22/css/books.min.css" type="text/css" /><link rel="stylesheet" href="/corehtml/pmc/css/bookshelf/2.22/css/books_print.min.css" type="text/css" media="print" /><style type="text/css">p a.figpopup{display:inline !important} .bk_tt {font-family: monospace}  .first-line-outdent .bk_ref {display: inline}  .body-content h2, .body-content .h2  {border-bottom: 1px solid #97B0C8} .body-content h2.inline {border-bottom: none} a.page-toc-label , .jig-ncbismoothscroll a {text-decoration:none;border:0 !important} .temp-labeled-list  .graphic {display:inline-block !important} .temp-labeled-list  img{width:100%}</style><script type="text/javascript" src="/corehtml/pmc/js/jquery.hoverIntent.min.js"> </script><script type="text/javascript" src="/corehtml/pmc/js/common.min.js"> </script><script type="text/javascript" src="/corehtml/pmc/js/large-obj-scrollbars.min.js"> </script><script type="text/javascript">window.name="mainwindow";</script><script type="text/javascript" src="/corehtml/pmc/js/bookshelf/2.22/book-toc.min.js"> </script><script type="text/javascript" src="/corehtml/pmc/js/bookshelf/2.22/books.min.js"> </script><meta name="book-collection" content="NONE" />

        <!-- Page meta end -->
    <link rel="shortcut icon" href="//www.ncbi.nlm.nih.gov/favicon.ico" /><meta name="ncbi_phid" content="CE8AD569DFC876A10000000006D30389.m_12" />
<meta name='referrer' content='origin-when-cross-origin'/><link type="text/css" rel="stylesheet" href="//static.pubmed.gov/portal/portal3rc.fcgi/4176521/css/3852956/3985586/3808861/4121862/3974050/3917732/251717/4098876/14534/45193/4113719/3849091/3984811/3751656/4033350/3840896/3577051/3852958/4008682/3881636/3579733/4062871/12930/3964959/3854974/36029/4128070/9685/3549676/3609192/3609193/3609213/3395586.css" /><link type="text/css" rel="stylesheet" href="//static.pubmed.gov/portal/portal3rc.fcgi/4176521/css/3411343/3882866.css" media="print" /></head>
    <body class="book-part">
        <div class="grid">
            <div class="col twelve_col nomargin shadow">
                <!-- System messages like service outage or JS required; this is handled by the TemplateResources portlet -->
                <div class="sysmessages">
                    <noscript>
	<p class="nojs">
	<strong>Warning:</strong>
	The NCBI web site requires JavaScript to function. 
	<a href="/guide/browsers/#enablejs" title="Learn how to enable JavaScript" target="_blank">more...</a>
	</p>
	</noscript>
                </div>
                <!--/.sysmessage-->
                <div class="wrap">
                    <div class="page">
                        <div class="top">
                            <div class="universal_header" id="universal_header"><ul class="inline_list jig-ncbimenu ui-ncbimenu resources_list" id="navcontent"><li class="ui-ncbimenu-item-leaf ui-ncbimenu-item-first ui-helper-reset ui-ncbimenu-item-no-hlt"><a class="ui-ncbimenu-link-first" href="/" role="banner" title="NCBI Home" id="ncbihome" accesskey="1"><span class="offscreen_noflow">NCBI</span><img src="//static.pubmed.gov/portal/portal3rc.fcgi/4176521/img/28977" class="ncbi_logo" title="NCBI" alt="NCBI Logo" /></a></li><li class="offscreen_noflow ui-ncbimenu-item-skip access"><a href="#maincontent" title="Skip to the content" tabindex="0" accesskey="3">Skip to main
                        content</a></li><li class="offscreen_noflow ui-ncbimenu-item-skip access"><a href="#navcontent" title="Skip to the navigation" tabindex="0" accesskey="4">Skip to
                        navigation</a></li><li id="resource-menu" class="topmenu ui-helper-reset ui-ncbimenu-item-first ui-helper-reset"><a class="ui-ncbimenu-first-link-has-submenu ui-ncbimenu-link-first topanchor expandDown" href="/static/header_footer_ajax/submenu/#resources">Resources</a></li><li id="all-howtos-menu" class="topmenu ui-helper-reset ui-ncbimenu-item-first"><a class="ui-ncbimenu-first-link-has-submenu ui-ncbimenu-link-first topanchor expandDown" href="/static/header_footer_ajax/submenu/#howto">How To</a></li><li class="offscreen_noflow ui-ncbimenu-item-skip access"><a href="/guide/browsers/#accesskeys" title="About My NCBI Accesskeys" tabindex="0" accesskey="0">About NCBI Accesskeys</a></li></ul><div class="myncbi"><span id="myncbiusername" style="display:none"><a href="/account/settings/" id="mnu" title="Edit account settings"></a></span><a accesskey="2" href="/myncbi/" id="myncbi" style="display:none">My NCBI</a><a href="/account/" id="sign_in">Sign in to NCBI</a><a href="/account/signout/" id="sign_out" style="display:none">Sign Out</a></div></div>
                            <div class="header">
    <div class="res_logo"><h1 class="res_name"><a href="/books/" title="Bookshelf home">Bookshelf</a></h1><h2 class="res_tagline"></h2></div>
    <div class="search"><form method="get" action="/books/"><div class="search_form"><label for="database" class="offscreen_noflow">Search database</label><select id="database"><optgroup label="Recent"><option value="books" selected="selected" class="last" data-ac_dict="bookshelf-search">Books</option></optgroup><optgroup label="All"><option value="gquery">All Databases</option><option value="assembly">Assembly</option><option value="biocollections">Biocollections</option><option value="bioproject">BioProject</option><option value="biosample">BioSample</option><option value="biosystems">BioSystems</option><option value="books" data-ac_dict="bookshelf-search">Books</option><option value="clinvar">ClinVar</option><option value="cdd">Conserved Domains</option><option value="gap">dbGaP</option><option value="dbvar">dbVar</option><option value="gene">Gene</option><option value="genome">Genome</option><option value="gds">GEO DataSets</option><option value="geoprofiles">GEO Profiles</option><option value="gtr">GTR</option><option value="homologene">HomoloGene</option><option value="ipg">Identical Protein Groups</option><option value="medgen">MedGen</option><option value="mesh">MeSH</option><option value="ncbisearch">NCBI Web Site</option><option value="nlmcatalog">NLM Catalog</option><option value="nuccore">Nucleotide</option><option value="omim">OMIM</option><option value="pmc">PMC</option><option value="popset">PopSet</option><option value="probe">Probe</option><option value="protein">Protein</option><option value="proteinclusters">Protein Clusters</option><option value="pcassay">PubChem BioAssay</option><option value="pccompound">PubChem Compound</option><option value="pcsubstance">PubChem Substance</option><option value="pubmed">PubMed</option><option value="snp">SNP</option><option value="sparcle">Sparcle</option><option value="sra">SRA</option><option value="structure">Structure</option><option value="taxonomy">Taxonomy</option><option value="toolkit">ToolKit</option><option value="toolkitall">ToolKitAll</option><option value="toolkitbookgh">ToolKitBookgh</option></optgroup></select><div class="nowrap"><label for="term" class="offscreen_noflow" accesskey="/">Search term</label><div class="nowrap"><input type="text" name="term" id="term" title="Search Books. Use up and down arrows to choose an item from the autocomplete." value="" class="jig-ncbiclearbutton jig-ncbiautocomplete" data-jigconfig="dictionary:'bookshelf-search',disableUrl:'NcbiSearchBarAutoComplCtrl'" autocomplete="off" data-sbconfig="ds:'no',pjs:'no',afs:'no'" /></div><button id="search" type="submit" class="button_search nowrap" cmd="go">Search</button></div></div></form><ul class="searchlinks inline_list"><li>
                        <a href="/books/browse/">Browse Titles</a>
                    </li><li>
                        <a href="/books/advanced/">Advanced</a>
                    </li><li class="help">
                        <a href="/books/NBK3833/">Help</a>
                    </li></ul></div>
</div>

                            
                            
                        <!--<component id="Page" label="headcontent"/>-->
                            
                        </div>
                        <div class="content">
                            <!-- site messages -->
                            <!-- Custom content 1 -->
<div class="col1">
    
</div>

<div class="container">
    <div id="maincontent" class="content eight_col col">
        <!-- Custom content in the left column above book nav -->
        <div class="col2">
            
        </div>
        
        <!-- Book content -->
        

        <!-- Custom content between navigation and content -->
        <div class="col3">
            
        </div>
        
        <div class="document">
            <div class="pre-content"><div><div class="bk_prnt"><p class="small">NCBI Bookshelf. A service of the National Library of Medicine, National Institutes of Health.</p><p>Adam MP, Ardinger HH, Pagon RA, et al., editors. GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle; 1993-2019. </p></div><div class="iconblock clearfix whole_rhythm no_top_margin bk_noprnt"><a class="img_link icnblk_img" title="All GeneReviews" href="/books/n/gene/"><img class="source-thumb" src="/corehtml/pmc/pmcgifs/bookshelf/thumbs/th-gene-lrg.png" alt="Cover of GeneReviews®" height="100px" width="80px" /></a><div class="icnblk_cntnt eight_col"><h2>GeneReviews<sup>®</sup> [Internet].</h2><a data-jig="ncbitoggler" href="#__NBK84551_dtls__">Show details</a><div style="display:none" class="ui-widget" id="__NBK84551_dtls__"><div>Adam MP, Ardinger HH, Pagon RA, et al., editors.</div><div>Seattle (WA): <a href="http://www.washington.edu" ref="pagearea=page-banner&amp;targetsite=external&amp;targetcat=link&amp;targettype=publisher">University of Washington, Seattle</a>; 1993-2019.</div></div><div class="half_rhythm"><ul class="inline_list"><li style="margin-right:1em"><a class="bk_cntns" href="/books/n/gene/">GeneReviews by Title</a></li></ul></div><div class="bk_noprnt"><form method="get" action="/books/n/gene/" id="bk_srch"><div class="bk_search"><label for="bk_term" class="offscreen_noflow">Search term</label><input type="text" title="Search GeneReviews" id="bk_term" name="term" value="" data-jig="ncbiclearbutton" /> <input type="submit" class="jig-ncbibutton" value="Search GeneReviews" submit="false" style="padding: 0.1em 0.4em;" /></div></form><div><ul class="inline_list"><li><a href="/books/n/gene/advanced/">GeneReviews Advanced Search</a></li><li style="margin-left:.5em"><a href="/books/n/gene/helpadvsearch/">Help</a></li></ul></div></div></div><div class="icnblk_cntnt two_col"><div class="pagination bk_noprnt"><a class="active page_link prev" href="/books/n/gene/iiae3/" title="Previous page in this title">&lt; Prev</a><a class="active page_link next" href="/books/n/gene/tango2-mea/" title="Next page in this title">Next &gt;</a></div></div></div></div></div>
            <div class="main-content lit-style" itemscope="itemscope" itemtype="http://schema.org/CreativeWork"><div class="meta-content fm-sec"><h1 id="_NBK84551_"><span class="title" itemprop="name">Systemic Primary Carnitine Deficiency</span></h1><div itemprop="alternativeHeadline" class="subtitle whole_rhythm">Synonyms: Carnitine Transport Defect, Carnitine Uptake Defect, CDSP</div><p class="contrib-group"><span itemprop="author">Ayman W El-Hattab</span>, MD, FAAP, FACMG.</p><a data-jig="ncbitoggler" href="#__NBK84551_ai__" style="border:0;text-decoration:none">Author Information</a><div style="display:none" class="ui-widget" id="__NBK84551_ai__"><div class="contrib half_rhythm"><span itemprop="author">Ayman W El-Hattab</span>, MD, FAAP, FACMG<div class="affiliation small">Associate Professor, Department of Clinical Sciences<br />College of Medicine<br />University of Sharjah<br />Sharjah, United Arab Emirates<div><span class="email-label">Email: </span><a href="mailto:dev@null" data-email="moc.oohay@wabattahle" class="oemail">moc.oohay@wabattahle</a></div></div></div></div><p class="small">Initial Posting: <span itemprop="datePublished">March 15, 2012</span>; Last Update: <span itemprop="dateModified">November 3, 2016</span>.</p><p><em>Estimated reading time: 15 minutes</em></p></div><div class="jig-ncbiinpagenav body-content whole_rhythm" data-jigconfig="allHeadingLevels: ['h2'],smoothScroll: false" itemprop="text"><div id="cdsp.Summary" itemprop="description"><h2 id="_cdsp_Summary_">Summary</h2><div><h4 class="inline">Clinical characteristics.</h4><p>Systemic primary carnitine deficiency (CDSP) is a disorder of the carnitine cycle that results in defective fatty acid oxidation. It encompasses a broad clinical spectrum including the following:</p><ul><li class="half_rhythm"><div>Metabolic decompensation in infancy typically presenting between age three months and two years with episodes of hypoketotic hypoglycemia, poor feeding, irritability, lethargy, hepatomegaly, elevated liver transaminases, and hyperammonemia triggered by fasting or common illnesses such as upper respiratory tract infection or gastroenteritis</div></li><li class="half_rhythm"><div>Childhood myopathy involving heart and skeletal muscle with onset between age two and four years</div></li><li class="half_rhythm"><div>Pregnancy-related decreased stamina or exacerbation of cardiac arrhythmia</div></li><li class="half_rhythm"><div>Fatigability in adulthood</div></li><li class="half_rhythm"><div>Absence of symptoms</div></li></ul><p>The latter two categories often include mothers diagnosed with CDSP after <a class="def" href="/books/n/gene/glossary/def-item/newborn-screening/">newborn screening</a> has identified low carnitine levels in their infants.</p></div><div><h4 class="inline">Diagnosis/testing.</h4><p>Plasma carnitine levels are extremely reduced in CDSP. The diagnosis is established by identification of <a class="def" href="/books/n/gene/glossary/def-item/biallelic/">biallelic</a> pathogenic variants in <i>SLC22A5</i> or demonstration of reduced fibroblast carnitine transport.</p></div><div><h4 class="inline">Management.</h4><p><i>Treatment of manifestations:</i> Metabolic decompensation and skeletal and cardiac muscle function improve with 100-400 mg/kg/day oral levocarnitine (L-carnitine) if it is started before irreversible organ damage occurs. Hypoglycemic episodes are treated with intravenous dextrose infusion; cardiomyopathy requires management by specialists in cardiology.</p><p><i>Prevention of primary manifestations:</i> Maintain appropriate plasma carnitine concentrations with oral L-carnitine supplementation; prevent hypoglycemia with frequent feeding and avoiding fasting. Hospitalization for intravenous glucose administration for individuals who are required to fast for a procedure or who cannot tolerate oral intake due to illness such as gastroenteritis.</p><p><i>Prevention of secondary complications:</i> Oral metronidazole and/or decreasing the carnitine dose usually results in the resolution of the fishy odor due to L-carnitine supplementation.</p><p><i>Surveillance:</i> Echocardiogram and electrocardiogram: annually during childhood and less frequently in adulthood; monitor plasma carnitine concentration frequently until levels reach the normal range, then, measure three times a year during infancy and early childhood, twice a year in older children, and annually in adults; evaluate serum creatine kinase concentration and liver transaminases during acute illnesses.</p><p><i>Agents/circumstances to avoid:</i> Fasting longer than age-appropriate periods.</p><p><i>Evaluation of relatives at risk:</i> Measure plasma carnitine levels in sibs of an <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individual.</p><p><i>Pregnancy management:</i> Pregnant women with CDSP require close monitoring of plasma carnitine levels and increased carnitine supplementation as needed to maintain normal plasma carnitine levels.</p></div><div><h4 class="inline">Genetic counseling.</h4><p>CDSP is inherited in an <a class="def" href="/books/n/gene/glossary/def-item/autosomal-recessive/">autosomal recessive</a> manner. At conception, each sib of an <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individual has a 25% chance of being affected, a 50% chance of being an asymptomatic <a class="def" href="/books/n/gene/glossary/def-item/carrier/">carrier</a>, and a 25% chance of being unaffected and not a carrier. Carrier testing for at-risk family members and <a class="def" href="/books/n/gene/glossary/def-item/prenatal-diagnosis/">prenatal diagnosis</a> for pregnancies at increased risk are possible if the <i>SLC22A5</i> pathogenic variants in the family are known.</p></div></div><div id="cdsp.Diagnosis"><h2 id="_cdsp_Diagnosis_">Diagnosis</h2><div id="cdsp.Suggestive_Findings"><h3>Suggestive Findings</h3><p>Systemic primary carnitine deficiency (CDSP) <b>should be suspected</b> in the following clinical situations:</p><ul><li class="half_rhythm"><div>Infant with positive <a class="def" href="/books/n/gene/glossary/def-item/newborn-screening/">newborn screening</a></div></li><li class="half_rhythm"><div>Infants with hypoketotic hypoglycemic episodes that may be associated with hepatomegaly, elevated transaminases, and hyperammonemia</div></li><li class="half_rhythm"><div>Children with skeletal myopathy and/or elevated serum concentration of creatine kinase (CK)</div></li><li class="half_rhythm"><div>Children with cardiomyopathy</div></li><li class="half_rhythm"><div>Adults with unexplained fatigability</div></li></ul></div><div id="cdsp.Preliminary_Testing"><h3>Preliminary Testing</h3><p><b>Newborn screening</b> using tandem mass spectrometry (MS/MS) detects low levels of free carnitine (C0) and can identify infants with CDSP and mothers with CDSP. Because carnitine is transferred from the placenta to the fetus during pregnancy, an infant&#x02019;s carnitine levels during the neonatal period can reflect those of the mother. Thus, unaffected infants born to <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> mothers can have low carnitine levels shortly after birth [<a class="bk_pop" href="#cdsp.REF.schimmenti.2007.441">Schimmenti et al 2007</a>, <a class="bk_pop" href="#cdsp.REF.elhattab.2010.19">El-Hattab et al 2010</a>, <a class="bk_pop" href="#cdsp.REF.lee.2010.46">Lee et al 2010</a>].</p><p>The ACMG recommends that total and free carnitine be determined in infants who screen positive. Extremely reduced plasma free, acylated, and total (i.e., the sum of free and acylated) carnitine levels (i.e., &#x0003c;10% of controls) are diagnostic of this disorder [<a class="bk_pop" href="#cdsp.REF.longo.2006.77">Longo et al 2006</a>].</p><p>In addition, plasma carnitine levels should be measured in all mothers of infants found to have low free carnitine levels on <a class="def" href="/books/n/gene/glossary/def-item/newborn-screening/">newborn screening</a> in order to determine if the mother (rather than the infant) has CDSP, or if both mother and infant have CDSP [<a class="bk_pop" href="#cdsp.REF.schimmenti.2007.441">Schimmenti et al 2007</a>, <a class="bk_pop" href="#cdsp.REF.elhattab.2010.19">El-Hattab et al 2010</a>, <a class="bk_pop" href="#cdsp.REF.lee.2010.46">Lee et al 2010</a>].</p><p><b>Other presentations.</b> In infants, children, and adults with other presentations plasma carnitine levels remain the mainstay of the initial laboratory diagnosis.</p><p>Of note, other biochemical studies may also have been done to address a broader differential diagnosis:</p><ul><li class="half_rhythm"><div><b>Plasma acylcarnitine profile.</b> Because of the low level of all acylcarnitine, this study may well be unsuccessful. If a profile can be generated, there is generally no specific elevation of any acylcarnitine species.</div></li><li class="half_rhythm"><div><b>Urine organic acid analysis.</b> Nonspecific dicarboxylic aciduria, common in the acute decompensation of many fatty acid oxidation disorders, has been reported in some <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals with CDSP as well.</div></li></ul></div><div id="cdsp.Establishing_the_Diagnosis"><h3>Establishing the Diagnosis</h3><p>The diagnosis of CDSP <b>is established</b> in a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a> by identification of <a class="def" href="/books/n/gene/glossary/def-item/biallelic/">biallelic</a> pathogenic variants in <i>SLC22A5</i> on <a class="def" href="/books/n/gene/glossary/def-item/molecular-genetic-testing/">molecular genetic testing</a> (see <a class="figpopup" href="/books/NBK84551/table/cdsp.T.molecular_genetic_testing_used_in/?report=objectonly" target="object" rid-figpopup="figcdspTmoleculargenetictestingusedin" rid-ob="figobcdspTmoleculargenetictestingusedin">Table 1</a>) or, if biallelic pathogenic variants cannot be identified, by use of a skin biopsy to assess carnitine transport in cultured fibroblasts.</p><p>Molecular genetic testing approaches can include <b>single-<a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> testing</b>, use of a <b><a class="def" href="/books/n/gene/glossary/def-item/multigene-panel/">multigene panel</a></b>, and <b>more comprehensive</b>
<b><a class="def" href="/books/n/gene/glossary/def-item/genomic/">genomic</a> testing</b>:</p><ul><li class="half_rhythm"><div class="half_rhythm"><b>Single-<a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> testing.</b> Sequence analysis of <i>SLC22A5</i> is performed first and followed by gene-targeted <a class="def" href="/books/n/gene/glossary/def-item/deletion-duplication-analysis/">deletion/duplication analysis</a> if only one or no <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> is found.</div></li><li class="half_rhythm"><div class="half_rhythm"><b>A <a class="def" href="/books/n/gene/glossary/def-item/multigene-panel/">multigene panel</a></b> that includes <i>SLC22A5</i> and other genes of interest (see <a href="#cdsp.Differential_Diagnosis">Differential Diagnosis</a>) may also be considered. Note: (1) The genes included in the panel and the diagnostic <a class="def" href="/books/n/gene/glossary/def-item/sensitivity/">sensitivity</a> of the testing used for each <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> vary by laboratory and are likely to change over time. (2) Some multigene panels may include genes not associated with the condition discussed in this <i>GeneReview</i>; thus, clinicians need to determine which multigene panel is most likely to identify the genetic cause of the condition at the most reasonable cost while limiting identification of variants of <a class="def" href="/books/n/gene/glossary/def-item/uncertain-significance/">uncertain significance</a> and pathogenic variants in genes that do not explain the underlying <a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a>. (3) In some laboratories, panel options may include a custom laboratory-designed panel and/or custom phenotype-focused <a class="def" href="/books/n/gene/glossary/def-item/exome/">exome</a> analysis that includes genes specified by the clinician. (4) Methods used in a panel may include <a class="def" href="/books/n/gene/glossary/def-item/sequence-analysis/">sequence analysis</a>, <a class="def" href="/books/n/gene/glossary/def-item/deletion-duplication-analysis/">deletion/duplication analysis</a>, and/or other non-sequencing-based tests.</div><div class="half_rhythm">For an introduction to multigene panels click <a href="/books/n/gene/app5/#app5.Multigene_Panels">here</a>. More detailed information for clinicians ordering genetic tests can be found <a href="/books/n/gene/app5/#app5.Multigene_Panels_FAQs">here</a>.</div></li><li class="half_rhythm"><div class="half_rhythm"><b>More comprehensive <a class="def" href="/books/n/gene/glossary/def-item/genomic/">genomic</a> testing</b> (when available) including <a class="def" href="/books/n/gene/glossary/def-item/exome-sequencing/">exome sequencing</a>, mitochondrial sequencing, and <a class="def" href="/books/n/gene/glossary/def-item/genome-sequencing/">genome sequencing</a> may be considered if serial single-<a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> testing (and/or use of a <a class="def" href="/books/n/gene/glossary/def-item/multigene-panel/">multigene panel</a> that includes <i>SLC22A5</i>) fails to confirm a diagnosis in an individual with features of CDSP. Such testing may provide or suggest a diagnosis not previously considered (e.g., mutation of a different gene or genes that results in a similar clinical presentation).</div><div class="half_rhythm">For an introduction to comprehensive <a class="def" href="/books/n/gene/glossary/def-item/genomic/">genomic</a> testing click <a href="/books/n/gene/app5/#app5.Comprehensive_Genomic_Testing">here</a>. More detailed information for clinicians ordering genomic testing can be found <a href="/books/n/gene/app5/#app5.Comprehensive_Genomic_Testing_1">here</a>.</div></li></ul><div id="cdsp.T.molecular_genetic_testing_used_in" class="table"><h3><span class="label">Table 1. </span></h3><div class="caption"><p>Molecular Genetic Testing Used in Systemic Primary Carnitine Deficiency</p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK84551/table/cdsp.T.molecular_genetic_testing_used_in/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__cdsp.T.molecular_genetic_testing_used_in_lrgtbl__"><table class="no_bottom_margin"><thead><tr><th id="hd_h_cdsp.T.molecular_genetic_testing_used_in_1_1_1_1" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Gene&#x000a0;<sup>1</sup></th><th id="hd_h_cdsp.T.molecular_genetic_testing_used_in_1_1_1_2" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Method</th><th id="hd_h_cdsp.T.molecular_genetic_testing_used_in_1_1_1_3" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Proportion of Probands with Pathogenic Variants&#x000a0;<sup>2</sup> Detectable by Method</th></tr></thead><tbody><tr><td headers="hd_h_cdsp.T.molecular_genetic_testing_used_in_1_1_1_1" rowspan="2" scope="row" colspan="1" style="text-align:left;vertical-align:middle;"><i>SLC22A5</i></td><td headers="hd_h_cdsp.T.molecular_genetic_testing_used_in_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Sequence analysis&#x000a0;<sup>3</sup></td><td headers="hd_h_cdsp.T.molecular_genetic_testing_used_in_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">~70%&#x000a0;<sup>4</sup></td></tr><tr><td headers="hd_h_cdsp.T.molecular_genetic_testing_used_in_1_1_1_2" colspan="1" scope="row" rowspan="1" style="text-align:left;vertical-align:middle;">Gene-targeted <a class="def" href="/books/n/gene/glossary/def-item/deletion-duplication-analysis/">deletion/duplication analysis</a>&#x000a0;<sup>5</sup></td><td headers="hd_h_cdsp.T.molecular_genetic_testing_used_in_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">6/96 <sup>6</sup></td></tr></tbody></table></div><div><div><dl class="temp-labeled-list small"><dt>1. </dt><dd><div id="cdsp.TF.1.1"><p class="no_margin">See <a href="/books/NBK84551/#cdsp.molgen.TA">Table A. Genes and Databases</a> for <a class="def" href="/books/n/gene/glossary/def-item/chromosome/">chromosome</a> <a class="def" href="/books/n/gene/glossary/def-item/locus/">locus</a> and protein.</p></div></dd><dt>2. </dt><dd><div id="cdsp.TF.1.2"><p class="no_margin">See <a href="#cdsp.Molecular_Genetics">Molecular Genetics</a> for information on allelic variants detected in this <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a>.</p></div></dd><dt>3. </dt><dd><div id="cdsp.TF.1.3"><p class="no_margin">Sequence analysis detects variants that are benign, likely benign, of <a class="def" href="/books/n/gene/glossary/def-item/uncertain-significance/">uncertain significance</a>, likely pathogenic, or pathogenic. Pathogenic variants may include small intragenic deletions/insertions and <a class="def" href="/books/n/gene/glossary/def-item/missense/">missense</a>, <a class="def" href="/books/n/gene/glossary/def-item/nonsense-variant/">nonsense</a>, and <a class="def" href="/books/n/gene/glossary/def-item/splice-site/">splice site</a> variants; typically, <a class="def" href="/books/n/gene/glossary/def-item/exon/">exon</a> or whole-<a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> deletions/duplications are not detected. For issues to consider in interpretation of <a class="def" href="/books/n/gene/glossary/def-item/sequence-analysis/">sequence analysis</a> results, click <a href="/books/n/gene/app2/">here</a>.</p></div></dd><dt>4. </dt><dd><div id="cdsp.TF.1.4"><p class="no_margin">In one study, <i>SLC22A5</i> sequencing performed in 70 infants with low carnitine levels detected by <a class="def" href="/books/n/gene/glossary/def-item/newborn-screening/">newborn screening</a> identified two pathogenic variants in 23 infants and one <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> in 25 infants; no pathogenic variants were detected in 22 infants [<a class="bk_pop" href="#cdsp.REF.li.2010.e1632">Li et al 2010</a>].</p></div></dd><dt>5. </dt><dd><div id="cdsp.TF.1.5"><p class="no_margin">Gene-targeted <a class="def" href="/books/n/gene/glossary/def-item/deletion-duplication-analysis/">deletion/duplication analysis</a> detects intragenic deletions or duplications. Methods used may include <a class="def" href="/books/n/gene/glossary/def-item/quantitative-pcr/">quantitative PCR</a>, long-range PCR, multiplex ligation-dependent probe amplification (MLPA), and a <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a>-targeted microarray designed to detect single-<a class="def" href="/books/n/gene/glossary/def-item/exon/">exon</a> deletions or duplications.</p></div></dd><dt>6. </dt><dd><div id="cdsp.TF.1.6"><p class="no_margin">The Human Gene Mutation Database (HGMD) (<a href="http://www.hgmd.cf.ac.uk" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">www<wbr style="display:inline-block"></wbr>​.hgmd.cf.ac.uk</a>)</p></div></dd></dl></div></div></div><p><b>Fibroblast carnitine transport (uptake).</b> Carnitine transport in skin fibroblasts from <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals is typically reduced below 10% of control rates [<a class="bk_pop" href="#cdsp.REF.longo.2006.77">Longo et al 2006</a>].</p></div></div><div id="cdsp.Clinical_Characteristics"><h2 id="_cdsp_Clinical_Characteristics_">Clinical Characteristics</h2><div id="cdsp.Clinical_Description"><h3>Clinical Description</h3><p>The clinical manifestations of systemic primary carnitine deficiency (CDSP) can vary widely with respect to age of onset, organ involvement, and severity of symptoms. The CDSP <a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a> encompasses a broad clinical spectrum including metabolic decompensation in infancy, cardiomyopathy in childhood, fatigability in adulthood, or absence of symptoms. CDSP has typically been associated with infantile metabolic presentation in about half of <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals and childhood myopathic presentation in the other half. However, adults with CDSP who have mild or no symptoms have been reported. Such milder phenotypes are expected to be underdiagnosed; therefore, it is difficult to determine the relative prevalence of different phenotypes associated with CDSP [<a class="bk_pop" href="#cdsp.REF.longo.2006.77">Longo et al 2006</a>, <a class="bk_pop" href="#cdsp.REF.elhattab.2015.107">El-Hattab &#x00026; Scaglia 2015</a>].</p><p><b>Infantile metabolic (hepatic) presentation.</b> Affected children can present between age three months and two years with episodes of metabolic decompensation triggered by fasting or common illnesses such as upper-respiratory tract infection or gastroenteritis. These episodes are characterized clinically by poor feeding, irritability, lethargy, and hepatomegaly. Laboratory evaluations usually reveal hypoketotic hypoglycemia (hypoglycemia with minimal or no ketones in urine), hyperammonemia, and elevated liver transaminases. If <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> children are not treated with intravenous dextrose infusion during episodes of metabolic decompensation (see <a href="#cdsp.Management">Management</a>), they may develop coma and die [<a class="bk_pop" href="#cdsp.REF.longo.2006.77">Longo et al 2006</a>, <a class="bk_pop" href="#cdsp.REF.elhattab.2015.107">El-Hattab &#x00026; Scaglia 2015</a>].</p><p><b>Childhood myopathic (cardiac) presentation.</b> The average age of myopathic presentation is between age two and four years, indicating that the myopathic manifestations of CDSP may develop over a longer period of time. Myopathic manifestations include dilated cardiomyopathy, hypotonia, skeletal muscle weakness, and elevated serum creatine kinase (CK). Death from cardiac failure can occur before the diagnosis is established, indicating that this presentation can be fatal if not treated. Older children with the infantile presentation may also develop myopathic manifestations including elevated CK, cardiomyopathy, and skeletal muscle weakness [<a class="bk_pop" href="#cdsp.REF.longo.2006.77">Longo et al 2006</a>, <a class="bk_pop" href="#cdsp.REF.elhattab.2015.107">El-Hattab &#x00026; Scaglia 2015</a>].</p><p><b>Adulthood presentation.</b> Several women have been diagnosed with CDSP after <a class="def" href="/books/n/gene/glossary/def-item/newborn-screening/">newborn screening</a> identified low carnitine levels in their infants. About half of those women complained of fatigability, whereas the other half were asymptomatic. One woman was found to have dilated cardiomyopathy and another had arrhythmias [<a class="bk_pop" href="#cdsp.REF.schimmenti.2007.441">Schimmenti et al 2007</a>, <a class="bk_pop" href="#cdsp.REF.elhattab.2010.19">El-Hattab et al 2010</a>, <a class="bk_pop" href="#cdsp.REF.lee.2010.46">Lee et al 2010</a>]. An asymptomatic adult male with CDSP has also been reported [<a class="bk_pop" href="#cdsp.REF.spiekerkoetter.2003.613">Spiekerkoetter et al 2003</a>].</p><p><b>Pregnancy-related symptoms.</b> Pregnancy is a metabolically challenging state because energy consumption significantly increases. In addition, during pregnancy plasma carnitine levels are physiologically lower than those of non-pregnant controls. Affected women can have decreased stamina or worsening of cardiac arrhythmia during pregnancy, suggesting that CDSP may manifest or exacerbate during pregnancy [<a class="bk_pop" href="#cdsp.REF.schimmenti.2007.441">Schimmenti et al 2007</a>, <a class="bk_pop" href="#cdsp.REF.elhattab.2010.19">El-Hattab et al 2010</a>].</p><p><b>Atypical manifestations.</b> Other manifestations reported in individuals with CDSP include the following:</p><ul><li class="half_rhythm"><div>Anemia [<a class="bk_pop" href="#cdsp.REF.cano.2008.163">Cano et al 2008</a>]</div></li><li class="half_rhythm"><div>Proximal muscle weakness and global developmental delays [<a class="bk_pop" href="#cdsp.REF.wang.2001.387">Wang et al 2001</a>]</div></li><li class="half_rhythm"><div>Respiratory distress [<a class="bk_pop" href="#cdsp.REF.erguven.2007.331">Erguven et al 2007</a>]</div></li><li class="half_rhythm"><div>Arrhythmias and electrocardiographic (ECG) abnormalities [<a class="bk_pop" href="#cdsp.REF.schimmenti.2007.441">Schimmenti et al 2007</a>, <a class="bk_pop" href="#cdsp.REF.lee.2010.46">Lee et al 2010</a>], including long QT syndrome [<a class="bk_pop" href="#cdsp.REF.de_biase.2012.87">De Biase et al 2012</a>]</div></li></ul><p><b>Heterozygous carriers.</b> Heterozygous carriers are asymptomatic [<a class="bk_pop" href="#cdsp.REF.amat_di_san_filippo.2008.162">Amat di San Filippo et al 2008</a>].</p><p><b>Prognosis.</b> Infantile metabolic and childhood myopathic presentations of CDSP can be fatal if untreated (see <a href="#cdsp.Management">Management</a>). The long-term prognosis is favorable as long as <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals remain on carnitine supplements. Repeated attacks of hypoglycemia or sudden death from arrhythmia have been described in affected individuals discontinuing carnitine supplementation [<a class="bk_pop" href="#cdsp.REF.longo.2006.77">Longo et al 2006</a>].</p></div><div id="cdsp.GenotypePhenotype_Correlations"><h3>Genotype-Phenotype Correlations</h3><p>Fibroblast carnitine transport is reduced in all <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals. However, it has been demonstrated that carnitine transport is higher in the fibroblasts of asymptomatic individuals than in the fibroblasts of symptomatic individuals. Nonsense and frameshift variants in <i>SLC22A5</i> are typically associated with lower carnitine transport and are more prevalent in symptomatic individuals whereas <a class="def" href="/books/n/gene/glossary/def-item/missense/">missense</a> variants and <a class="def" href="/books/n/gene/glossary/def-item/in-frame/">in-frame</a> deletions may result in protein with retained residual carnitine transport activity and are more prevalent in asymptomatic individuals [<a class="bk_pop" href="#cdsp.REF.rose.2012.118">Rose et al 2012</a>].</p></div><div id="cdsp.Prevalence"><h3>Prevalence</h3><p>CDSP has a frequency of 1:20,000-1:70,000 in the United States [<a class="bk_pop" href="#cdsp.REF.magoulas.2012.68">Magoulas &#x00026; El-Hattab 2012</a>], 1:40,000 in Japan [<a class="bk_pop" href="#cdsp.REF.koizumi.1999.2247">Koizumi et al 1999</a>], and 1:120,000 in Australia [<a class="bk_pop" href="#cdsp.REF.wilcken.2003.2304">Wilcken et al 2003</a>]. The disease is very common in the Faroe Islands, where the prevalence is 1:300 [<a class="bk_pop" href="#cdsp.REF.rasmussen.2014.215">Rasmussen et al 2014</a>].</p></div></div><div id="cdsp.Genetically_Related_Allelic_Disorde"><h2 id="_cdsp_Genetically_Related_Allelic_Disorde_">Genetically Related (Allelic) Disorders</h2><p>No phenotypes other than those discussed in this <i>GeneReview</i> are known to be associated with pathogenic variants in <i>SLC22A5.</i></p></div><div id="cdsp.Differential_Diagnosis"><h2 id="_cdsp_Differential_Diagnosis_">Differential Diagnosis</h2><p>Systemic primary carnitine deficiency (CDSP) needs to be differentiated from secondary carnitine deficiency seen in the following situations [<a class="bk_pop" href="#cdsp.REF.flanagan.2010.30">Flanagan et al 2010</a>]:</p><ul><li class="half_rhythm"><div>Inherited metabolic disorders including organic acidemias and fatty acid oxidation defects (e.g., <a href="/books/n/gene/vlcad/">very long chain acyl-CoA dehydrogenase [VLCAD] deficiency</a>, <a href="/books/n/gene/mcad/">medium-chain acyl-CoA dehydrogenase [MCAD] deficiency</a>, <a href="/books/n/gene/scad/">short-chain acyl-CoA dehydrogenase [SCAD] deficiency</a>, carnitine-acylcarnitine translocase [CACT] deficiency [OMIM <a href="http://omim.org/entry/212138" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">212138</a>], long-chain hydroxyacyl-CoA dehydrogenase [LCHAD] deficiency [OMIM <a href="http://omim.org/entry/609016" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">609016</a>], and <a href="/books/n/gene/cpt2/">carnitine palmitoyltransferase II [CPT II] deficiency</a>)</div></li><li class="half_rhythm"><div>Pharmacologic therapy (e.g., valproate, cyclosporine, pivampicillin)</div></li><li class="half_rhythm"><div>Malnutrition</div></li><li class="half_rhythm"><div>Hemodialysis and renal tubular dysfunction (e.g., renal Fanconi syndrome)</div></li><li class="half_rhythm"><div>Prematurity. Premature neonates may have mild reduction in plasma carnitine concentrations due to a lack of carnitine placental transfer in the third trimester and decreased tissue stores. Moreover, immature renal tubular function in premature neonates could lead to increased renal carnitine elimination [<a class="bk_pop" href="#cdsp.REF.li.2010.e1632">Li et al 2010</a>, <a class="bk_pop" href="#cdsp.REF.clark.2014.e37">Clark et al 2014</a>].</div></li></ul></div><div id="cdsp.Management"><h2 id="_cdsp_Management_">Management</h2><div id="cdsp.Evaluations_Following_Initial_Diagn"><h3>Evaluations Following Initial Diagnosis</h3><p>To establish the extent of disease and needs of an individual diagnosed with systemic primary carnitine deficiency (CDSP), the following evaluations are recommended:</p><ul><li class="half_rhythm"><div>Echocardiogram and electrocardiogram</div></li><li class="half_rhythm"><div>Serum creatine kinase (CK) concentration</div></li><li class="half_rhythm"><div>Liver transaminases</div></li><li class="half_rhythm"><div>Pre-prandial blood glucose concentration</div></li><li class="half_rhythm"><div>Consultation with a clinical geneticist and/or genetic counselor</div></li></ul></div><div id="cdsp.Treatment_of_Manifestations"><h3>Treatment of Manifestations</h3><p><b>L-carnitine supplementation</b>. The main treatment for CDSP is oral levocarnitine (L-carnitine) supplementation. Typically, a high dose (100-400 mg/kg/day, divided in 3 doses) is required. Individuals with CDSP respond well if oral L-carnitine supplementation is started before irreversible organ damage occurs. Metabolic decompensation and skeletal and cardiac muscle function improve with L-carnitine supplementations.</p><p>Oral L-carnitine supplementation in infants with CDSP identified through <a class="def" href="/books/n/gene/glossary/def-item/newborn-screening/">newborn screening</a> results in slow normalization of the plasma carnitine concentration. The carnitine dose needs to be adjusted according to the plasma carnitine concentrations, which should be measured frequently.</p><p>L-carnitine supplementation has relatively few side effects:</p><ul><li class="half_rhythm"><div>High doses of oral L-carnitine can cause increased gastrointestinal motility, diarrhea, and intestinal discomfort.</div></li><li class="half_rhythm"><div>Oral L-carnitine can be metabolized by intestinal bacteria to produce trimethylamine, which has a fishy odor. Oral metronidazole at a dose of 10 mg/kg/day for 7-10 days and/or decreasing the carnitine dose usually results in the resolution of the odor [<a class="bk_pop" href="#cdsp.REF.longo.2006.77">Longo et al 2006</a>].</div></li></ul><p>Note: (1) An unaffected infant born to a mother with CDSP can have low carnitine levels detected on <a class="def" href="/books/n/gene/glossary/def-item/newborn-screening/">newborn screening</a>; in these infants oral L-carnitine supplementation is followed by a rise in plasma carnitine concentration within days or a few weeks [<a class="bk_pop" href="#cdsp.REF.schimmenti.2007.441">Schimmenti et al 2007</a>, <a class="bk_pop" href="#cdsp.REF.elhattab.2010.19">El-Hattab et al 2010</a>]. (2) Asymptomatic adults with CDSP have been reported; however, the limited literature and the lack of follow up make it unclear whether these individuals have potential health risks. Because some fatty acid oxidation defects such as <a href="/books/n/gene/mcad/">medium chain acyl CoA dehydrogenase (MCAD) deficiency</a> can remain asymptomatic until they results in sudden death or another acute presentation during stress, it is prudent to treat asymptomatic individuals with CDSP with L-carnitine supplementation to prevent the possibility of decompensation during intercurrent illness or stress [<a class="bk_pop" href="#cdsp.REF.elhattab.2010.19">El-Hattab et al 2010</a>].</p><p><b>Other</b></p><ul><li class="half_rhythm"><div>Hypoglycemic episodes are treated with intravenous dextrose infusion.</div></li><li class="half_rhythm"><div>Cardiomyopathy requires management by specialists in cardiology.</div></li></ul></div><div id="cdsp.Prevention_of_Primary_Manifestation"><h3>Prevention of Primary Manifestations</h3><p>Maintaining appropriate plasma carnitine concentrations through oral L-carnitine supplementation (see <a href="#cdsp.Treatment_of_Manifestations">Treatment of Manifestations</a>) and preventing hypoglycemia (with frequent feeding and avoiding fasting) typically eliminate the risk of metabolic, hepatic, cardiac, and muscular complications.</p><p>Note: Hospitalization to administer intravenous glucose is recommended for individuals with CDSP who are required to fast because of medical or surgical procedures or who cannot tolerate oral intake because of an illness such as gastroenteritis.</p></div><div id="cdsp.Prevention_of_Secondary_Complicatio"><h3>Prevention of Secondary Complications</h3><p>L-carnitine supplementation is well tolerated and has relatively few side effects: increased gastrointestinal motility, diarrhea, and a fishy odor. Oral metronidazole and/or decreasing the carnitine dose usually results in the resolution of the odor.</p></div><div id="cdsp.Surveillance"><h3>Surveillance</h3><p>The following evaluations have been suggested [<a class="bk_pop" href="#cdsp.REF.magoulas.2012.68">Magoulas &#x00026; El-Hattab 2012</a>]:</p><ul><li class="half_rhythm"><div>Echocardiogram and electrocardiogram. Perform annually during childhood and less frequently in adulthood. Individuals with cardiomyopathy require management and follow up by specialists in cardiology.</div></li><li class="half_rhythm"><div>Plasma carnitine concentration. Monitor frequently until levels reach the normal range, thereafter, measure three times a year during infancy and early childhood, twice a year in older children, and annually in adults.</div></li><li class="half_rhythm"><div>Serum CK concentration and liver transaminases. Consider measuring during acute illnesses.</div></li></ul></div><div id="cdsp.AgentsCircumstances_to_Avoid"><h3>Agents/Circumstances to Avoid</h3><p>Individuals with CDSP should avoid fasting longer than age-appropriate periods.</p></div><div id="cdsp.Evaluation_of_Relatives_at_Risk"><h3>Evaluation of Relatives at Risk</h3><p>Sibs of <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals should be tested by measuring plasma carnitine concentrations. If the carnitine levels are low, further evaluation for CDSP is recommended by <a class="def" href="/books/n/gene/glossary/def-item/molecular-genetic-testing/">molecular genetic testing</a> if the <i>SLC22A5</i> pathogenic variants have been identified in the family or fibroblast carnitine transport assay.</p><p>See <a href="#cdsp.Related_Genetic_Counseling_Issues">Genetic Counseling</a> for issues related to testing of at-risk relatives for <a class="def" href="/books/n/gene/glossary/def-item/genetic-counseling/">genetic counseling</a> purposes.</p></div><div id="cdsp.Pregnancy_Management"><h3>Pregnancy Management</h3><p>Pregnancy is a metabolically challenging state because energy consumption significantly increases. In addition, plasma carnitine levels are physiologically lower during pregnancy than those of non-pregnant controls. Affected women can have decreased stamina or worsening of cardiac arrhythmia during pregnancy, suggesting that CDSP may manifest or exacerbate during pregnancy [<a class="bk_pop" href="#cdsp.REF.schimmenti.2007.441">Schimmenti et al 2007</a>, <a class="bk_pop" href="#cdsp.REF.elhattab.2010.19">El-Hattab et al 2010</a>]. Therefore, all pregnant women with CDSP, including those who are asymptomatic, require close monitoring of plasma carnitine levels and increased carnitine supplementation as needed to maintain normal plasma carnitine levels.</p></div><div id="cdsp.Therapies_Under_Investigation"><h3>Therapies Under Investigation</h3><p>Search <a href="http://clinicaltrials.gov/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">ClinicalTrials.gov</a> in the US and <a href="http://www.clinicaltrialsregister.eu/ctr-search/search" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">EU Clinical Trials Register</a> in Europe for access to information on clinical studies for a wide range of diseases and conditions. Note: There may not be clinical trials for this disorder.</p></div></div><div id="cdsp.Genetic_Counseling"><h2 id="_cdsp_Genetic_Counseling_">Genetic Counseling</h2><p>
<i>Genetic counseling is the process of providing individuals and families with
information on the nature, inheritance, and implications of genetic disorders to help them
make informed medical and personal decisions. The following section deals with genetic
risk assessment and the use of family history and genetic testing to clarify genetic
status for family members. This section is not meant to address all personal, cultural, or
ethical issues that individuals may face or to substitute for consultation with a genetics
professional</i>. &#x02014;ED.</p><div id="cdsp.Mode_of_Inheritance"><h3>Mode of Inheritance</h3><p>Systemic primary carnitine deficiency (CDSP) is inherited in an <a class="def" href="/books/n/gene/glossary/def-item/autosomal-recessive/">autosomal recessive</a> manner.</p></div><div id="cdsp.Risk_to_Family_Members"><h3>Risk to Family Members</h3><p><b>Parents of a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a></b></p><ul><li class="half_rhythm"><div>The parents of an <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individual are obligate heterozygotes (i.e., carriers of one <i>SLC22A5</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a>). Occasionally an asymptomatic parent is found to have <a class="def" href="/books/n/gene/glossary/def-item/biallelic/">biallelic</a> <i>SLC22A5</i> pathogenic variants.</div></li><li class="half_rhythm"><div>Heterozygotes (carriers) are asymptomatic and are not at risk of developing the disorder.</div></li></ul><p><b>Sibs of a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a></b></p><ul><li class="half_rhythm"><div>At conception, each sib of an <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individual has a 25% chance of being affected, a 50% chance of being an asymptomatic <a class="def" href="/books/n/gene/glossary/def-item/carrier/">carrier</a>, and a 25% chance of being unaffected and not a carrier.</div></li><li class="half_rhythm"><div>Heterozygotes (carriers) are asymptomatic and are not at risk of developing the disorder.</div></li></ul><p><b>Offspring of a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a>.</b> The offspring of an individual with systemic primary carnitine deficiency are obligate heterozygotes (carriers) for an <i>SLC22A5</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a>.</p><p><b>Other family members.</b> Each sib of the <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a>&#x02019;s parents is at a 50% risk of being a <a class="def" href="/books/n/gene/glossary/def-item/carrier/">carrier</a> of an <i>SLC22A5</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a>.</p></div><div id="cdsp.Carrier_Heterozygote_Detection"><h3>Carrier (Heterozygote) Detection</h3><p><b>Molecular genetic testing.</b> Carrier testing for at-risk relatives requires prior identification of the <i>SLC22A5</i> pathogenic variants in the family.</p><p><b>Biochemical testing.</b> Heterozygous carriers usually have about 50% carnitine transport activity in fibroblasts and can have borderline low plasma carnitine levels. However, normal plasma carnitine levels have been reported in some <a class="def" href="/books/n/gene/glossary/def-item/heterozygous/">heterozygous</a> carriers. Because the diet, which provides about 75% of the daily requirement of carnitine, may play a role in modulating carnitine levels, plasma carnitine levels are not a reliable indicator for heterozygous <a class="def" href="/books/n/gene/glossary/def-item/carrier/">carrier</a> status; thus, either molecular testing of <i>SLC22A5</i> or fibroblast carnitine transport assay is needed to determine carrier status [<a class="bk_pop" href="#cdsp.REF.elhattab.2010.19">El-Hattab et al 2010</a>].</p></div><div id="cdsp.Related_Genetic_Counseling_Issues"><h3>Related Genetic Counseling Issues</h3><p>See Management, <a href="#cdsp.Evaluation_of_Relatives_at_Risk">Evaluation of Relatives at Risk</a> for information on evaluating at-risk relatives for the purpose of early diagnosis and treatment.</p><p><b>Family planning</b></p><ul><li class="half_rhythm"><div>The optimal time for determination of genetic risk, clarification of <a class="def" href="/books/n/gene/glossary/def-item/carrier/">carrier</a> status, and discussion of the availability of prenatal testing is before pregnancy.</div></li><li class="half_rhythm"><div>It is appropriate to offer <a class="def" href="/books/n/gene/glossary/def-item/genetic-counseling/">genetic counseling</a> (including discussion of potential risks to offspring and reproductive options) to young adults who are <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a>, are carriers, or are at risk of being carriers.</div></li></ul><p><b>DNA banking</b> is the storage of DNA (typically extracted from white blood cells) for possible future use. Because it is likely that testing methodology and our understanding of genes, allelic variants, and diseases will improve in the future, consideration should be given to banking DNA of <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals.</p></div><div id="cdsp.Prenatal_Testing_and_Preimplantatio"><h3>Prenatal Testing and Preimplantation Genetic Diagnosis</h3><p>Once the <i>SLC22A5</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> has been identified in an <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> family member, prenatal testing for a pregnancy at increased risk and <a class="def" href="/books/n/gene/glossary/def-item/preimplantation-genetic-diagnosis/">preimplantation genetic diagnosis</a> are possible.</p><p>Differences in perspective may exist among medical professionals and within families regarding the use of prenatal testing, particularly if the testing is being considered for the purpose of pregnancy termination rather than early diagnosis. While decisions regarding prenatal testing are the choice of the parents, discussion of these issues is appropriate.</p></div></div><div id="cdsp.Resources"><h2 id="_cdsp_Resources_">Resources</h2><p>
<i>GeneReviews staff has selected the following disease-specific and/or umbrella
support organizations and/or registries for the benefit of individuals with this disorder
and their families. GeneReviews is not responsible for the information provided by other
organizations. For information on selection criteria, click <a href="/books/n/gene/app4/">here</a>.</i></p><ul><li class="half_rhythm"><div><b>My46 Trait Profile</b></div><div><a href="https://www.my46.org/trait-document?trait=Primary%20carnitine%20deficiency&#x00026;parent=Metabolic%20Disorders&#x00026;type=profile" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">Primary carnitine deficiency</a></div></li><li class="half_rhythm"><div><b>National Library of Medicine Genetics Home Reference</b></div><div><a href="http://ghr.nlm.nih.gov/condition=primarycarnitinedeficiency" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">Primary carnitine deficiency</a></div></li><li class="half_rhythm"><div><b>FOD Family Support Group (Fatty Oxidation Disorder)</b></div><div>PO Box 54</div><div>Okemos MI 48805-0054</div><div><b>Phone:</b> 517-381-1940</div><div><b>Fax:</b> 866-290-5206 (toll-free)</div><div><b>Email:</b> deb@fodsupport.org; fodgroup@gmail.com</div><div><a href="http://www.fodsupport.org" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">www.fodsupport.org</a></div></li><li class="half_rhythm"><div><b>Metabolic Support UK</b></div><div>5 Hilliards Court, Sandpiper Way</div><div>Chester Business Park</div><div>Chester CH4 9QP </div><div>United Kingdom</div><div><b>Phone:</b> 0845 241 2173</div><div><b>Email:</b> contact@metabolicsupportuk.org</div><div><a href="https://www.metabolicsupportuk.org/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">www.metabolicsupportuk.org</a></div></li></ul></div><div id="cdsp.Molecular_Genetics"><h2 id="_cdsp_Molecular_Genetics_">Molecular Genetics</h2><p><i>Information in the Molecular Genetics and OMIM tables may differ from that elsewhere in the GeneReview: tables may contain more recent information. &#x02014;</i>ED.</p><div id="cdsp.molgen.TA" class="table"><h3><span class="label">Table A.</span></h3><div class="caption"><p>Systemic Primary Carnitine Deficiency: Genes and Databases</p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK84551/table/cdsp.molgen.TA/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__cdsp.molgen.TA_lrgtbl__"><table class="no_bottom_margin"><tbody><tr><th id="hd_b_cdsp.molgen.TA_1_1_1_1" rowspan="1" colspan="1" style="vertical-align:top;">Gene</th><th id="hd_b_cdsp.molgen.TA_1_1_1_2" rowspan="1" colspan="1" style="vertical-align:top;">Chromosome Locus</th><th id="hd_b_cdsp.molgen.TA_1_1_1_3" rowspan="1" colspan="1" style="vertical-align:top;">Protein</th><th id="hd_b_cdsp.molgen.TA_1_1_1_4" rowspan="1" colspan="1" style="vertical-align:top;">Locus-Specific Databases</th><th id="hd_b_cdsp.molgen.TA_1_1_1_5" rowspan="1" colspan="1" style="vertical-align:top;">HGMD</th><th id="hd_b_cdsp.molgen.TA_1_1_1_6" rowspan="1" colspan="1" style="vertical-align:top;">ClinVar</th></tr><tr><td headers="hd_b_cdsp.molgen.TA_1_1_1_1" rowspan="1" colspan="1" style="vertical-align:top;"><a href="/gene/6584" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=gene"><i>SLC22A5</i></a></td><td headers="hd_b_cdsp.molgen.TA_1_1_1_2" rowspan="1" colspan="1" style="vertical-align:top;"><a href="https://www.ncbi.nlm.nih.gov/genome/gdv/?context=gene&#x00026;acc=6584" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">5q31<wbr style="display:inline-block"></wbr>​.1</a></td><td headers="hd_b_cdsp.molgen.TA_1_1_1_3" rowspan="1" colspan="1" style="vertical-align:top;"><a href="http://www.uniprot.org/uniprot/O76082" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">Solute carrier family 22 member 5</a></td><td headers="hd_b_cdsp.molgen.TA_1_1_1_4" rowspan="1" colspan="1" style="vertical-align:top;"><a href="http://databases.lovd.nl/shared/genes/SLC22A5" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">SLC22A5 database</a></td><td headers="hd_b_cdsp.molgen.TA_1_1_1_5" rowspan="1" colspan="1" style="vertical-align:top;"><a href="http://www.hgmd.cf.ac.uk/ac/gene.php?gene=SLC22A5" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">SLC22A5</a></td><td headers="hd_b_cdsp.molgen.TA_1_1_1_6" rowspan="1" colspan="1" style="vertical-align:top;"><a href="https://www.ncbi.nlm.nih.gov/clinvar/?term=SLC22A5[gene]" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">SLC22A5</a></td></tr></tbody></table></div><div><div><dl class="temp-labeled-list small"><dt></dt><dd><div id="cdsp.TFA.1"><p class="no_margin">Data are compiled from the following standard references: <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> from
<a href="http://www.genenames.org/index.html" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">HGNC</a>;
<a class="def" href="/books/n/gene/glossary/def-item/chromosome/">chromosome</a> <a class="def" href="/books/n/gene/glossary/def-item/locus/">locus</a> from
<a href="http://www.omim.org/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">OMIM</a>;
protein from <a href="http://www.uniprot.org/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">UniProt</a>.
For a description of databases (Locus Specific, HGMD, ClinVar) to which links are provided, click
<a href="/books/n/gene/app1/">here</a>.</p></div></dd></dl></div></div></div><div id="cdsp.molgen.TB" class="table"><h3><span class="label">Table B.</span></h3><div class="caption"><p>OMIM Entries for Systemic Primary Carnitine Deficiency (<a href="/omim/212140,603377" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=term&amp;targettype=omim">View All in OMIM</a>) </p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK84551/table/cdsp.molgen.TB/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__cdsp.molgen.TB_lrgtbl__"><table><tbody><tr><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">
<a href="/omim/212140" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=term&amp;targettype=omim">212140</a></td><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">CARNITINE DEFICIENCY, SYSTEMIC PRIMARY; CDSP</td></tr><tr><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">
<a href="/omim/603377" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=term&amp;targettype=omim">603377</a></td><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">SOLUTE CARRIER FAMILY 22 (ORGANIC CATION TRANSPORTER), MEMBER 5; SLC22A5</td></tr></tbody></table></div></div><div id="cdsp.Molecular_Pathogenesis"><h3>Molecular Pathogenesis</h3><p>Carnitine is required for the transfer of long-chain fatty acids from the cytoplasm to the mitochondrial matrix for beta-oxidation. During periods of fasting, fatty acids are the predominant substrate for energy production via oxidation in the liver, cardiac muscle, and skeletal muscle. Carnitine is transported inside the cells by an organic cation transporter (OCTN2) present in the heart, muscle, and kidney. OCTN2 is the protein product of <i>SLC22A5</i>. CDSP is a disorder of the carnitine cycle caused by the lack of functional OCTN2 resulting in urinary carnitine wasting, low plasma carnitine levels, and decreased intracellular carnitine accumulation.</p><p>Carnitine deficiency results in defective fatty acid oxidation. When fat cannot be utilized glucose is consumed without regeneration via gluconeogenesis, resulting in hypoglycemia. In addition, fats released from adipose tissue accumulate in the liver, skeletal muscle, and heart, resulting in hepatic steatosis and myopathy [<a class="bk_pop" href="#cdsp.REF.longo.2006.77">Longo et al 2006</a>, <a class="bk_pop" href="#cdsp.REF.elhattab.2015.107">El-Hattab &#x00026; Scaglia 2015</a>].</p><p><b>Gene structure.</b>
<i>SLC22A5</i> comprises ten exons spanning approximately 3.2 kb. For a detailed summary of <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> and protein information, see <a href="/books/NBK84551/#cdsp.molgen.TA">Table A</a>, <b>Gene</b>.</p><p><b>Pathogenic variants.</b> To date more than 180 pathogenic variants have been reported in the <i>SLC22A5</i> database at ARUP Laboratories (see <a href="/books/NBK84551/#cdsp.molgen.TA">Table A</a>).</p><p>About half of these pathogenic variants are <a class="def" href="/books/n/gene/glossary/def-item/missense/">missense</a> variants. Nonsense variants, <a class="def" href="/books/n/gene/glossary/def-item/splice-site/">splice site</a> variants, insertions, and small deletions comprise the remaining half of reported pathogenic variants.</p><p>Six large deletions involving <i>SLC22A5</i> have been described at the Human Gene Mutation Database (HGMD) (<a href="http://www.hgmd.cf.ac.uk" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">www.hgmd.cf.ac.uk</a>).</p><p><b>Normal <a class="def" href="/books/n/gene/glossary/def-item/gene-product/">gene product</a>.</b>
<i>SLC22A5</i> encodes the high-affinity sodium-dependent carnitine transporter, organic cation transporter 2 (OCTN2). OCTN2 is a transmembrane protein that comprises 557 amino acids; it includes 12 transmembrane domains and one ATP binding <a class="def" href="/books/n/gene/glossary/def-item/domain/">domain</a>.</p><p><b>Abnormal <a class="def" href="/books/n/gene/glossary/def-item/gene-product/">gene product</a>.</b>
<i>SLC22A5</i> pathogenic variants result in dysfunctional OCTN2 and decreased carnitine transport in various tissues.</p></div></div><div id="cdsp.References"><h2 id="_cdsp_References_">References</h2><div id="cdsp.Literature_Cited"><h3>Literature Cited</h3><ul class="simple-list"><li class="half_rhythm"><div class="bk_ref" id="cdsp.REF.amat_di_san_filippo.2008.162">Amat di San Filippo C, Taylor MR, Mestroni L, Botto LD, Longo N. Cardiomyopathy and carnitine deficiency. <span><span class="ref-journal">Mol Genet Metab. </span>2008;<span class="ref-vol">94</span>:162–6.</span> [<a href="/pmc/articles/PMC2430214/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC2430214</span></a>] [<a href="/pubmed/18337137" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 18337137</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="cdsp.REF.cano.2008.163">Cano A, Ovaert C, Vianey-Saban C, Chabrol B. Carnitine membrane transporter deficiency: a rare treatable cause of cardiomyopathy and anemia. <span><span class="ref-journal">Pediatr Cardiol. </span>2008;<span class="ref-vol">29</span>:163–5.</span> [<a href="/pubmed/17926086" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 17926086</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="cdsp.REF.clark.2014.e37">Clark RH, Kelleher AS, Chace DH, Spitzer AR. Gestational age and age at sampling influence metabolic profiles in premature infants. <span><span class="ref-journal">Pediatrics. </span>2014;<span class="ref-vol">134</span>:e37–46.</span> [<a href="/pubmed/24913786" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 24913786</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="cdsp.REF.de_biase.2012.87">De Biase I, Champaigne NL, Schroer R, Pollard LM, Longo N, Wood T. Primary Carnitine Deficiency Presents Atypically with Long QT Syndrome: A Case Report. <span><span class="ref-journal">JIMD Rep. </span>2012;<span class="ref-vol">2</span>:87–90.</span> [<a href="/pmc/articles/PMC3509843/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC3509843</span></a>] [<a href="/pubmed/23430858" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 23430858</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="cdsp.REF.elhattab.2010.19">El-Hattab AW, Li FY, Shen J, Powell BR, Bawle EV, Adams DJ, Wahl E, Kobori JA, Graham B, Scaglia F, Wong LJ. Maternal systemic primary carnitine deficiency uncovered by newborn screening: clinical, biochemical, and molecular aspects. <span><span class="ref-journal">Genet Med. </span>2010;<span class="ref-vol">12</span>:19–24.</span> [<a href="/pubmed/20027113" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 20027113</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="cdsp.REF.elhattab.2015.107">El-Hattab AW, Scaglia F. Disorders of carnitine biosynthesis and transport. <span><span class="ref-journal">Mol Genet Metab. </span>2015;<span class="ref-vol">116</span>:107–12.</span> [<a href="/pubmed/26385306" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 26385306</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="cdsp.REF.erguven.2007.331">Erguven M, Yilmaz O, Koc S, Caki S, Ayhan Y, Donmez M, Dolunay G. A case of early diagnosed carnitine deficiency presenting with respiratory symptoms. <span><span class="ref-journal">Ann Nutr Metab. </span>2007;<span class="ref-vol">51</span>:331–4.</span> [<a href="/pubmed/17726310" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 17726310</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="cdsp.REF.flanagan.2010.30">Flanagan JL, Simmons PA, Vehige J, Willcox MD, Garrett Q. Role of carnitine in disease. <span><span class="ref-journal">Nutr Metab (Lond). </span>2010;<span class="ref-vol">7</span>:30.</span> [<a href="/pmc/articles/PMC2861661/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC2861661</span></a>] [<a href="/pubmed/20398344" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 20398344</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="cdsp.REF.koizumi.1999.2247">Koizumi A, Nozaki J, Ohura T, Kayo T, Wada Y, Nezu J, Ohashi R, Tamai I, Shoji Y, Takada G, Kibira S, Matsuishi T, Tsuji A. Genetic epidemiology of the carnitine transporter OCTN2 gene in a Japanese population and phenotypic characterization in Japanese pedigrees with primary systemic carnitine deficiency. <span><span class="ref-journal">Hum Mol Genet. </span>1999;<span class="ref-vol">8</span>:2247–54.</span> [<a href="/pubmed/10545605" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 10545605</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="cdsp.REF.lee.2010.46">Lee NC, Tang NL, Chien YH, Chen CA, Lin SJ, Chiu PC, Huang AC, Hwu WL. Diagnoses of newborns and mothers with carnitine uptake defects through newborn screening. <span><span class="ref-journal">Mol Genet Metab. </span>2010;<span class="ref-vol">100</span>:46–50.</span> [<a href="/pubmed/20074989" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 20074989</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="cdsp.REF.li.2010.e1632">Li FY, El-Hattab AW, Bawle EV, Boles RG, Schmitt ES, Scaglia F, Wong LJ. Molecular spectrum of SLC22A5 (OCTN2) gene mutations detected in 143 subjects evaluated for systemic carnitine deficiency. <span><span class="ref-journal">Hum Mutat. </span>2010;<span class="ref-vol">31</span>:E1632–51.</span> [<a href="/pubmed/20574985" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 20574985</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="cdsp.REF.longo.2006.77">Longo N, Amat di San Filippo C, Pasquali M. Disorders of carnitine transport and the carnitine cycle. <span><span class="ref-journal">Am J Med Genet C Semin Med Genet. </span>2006;<span class="ref-vol">142C</span>:77–85.</span> [<a href="/pmc/articles/PMC2557099/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC2557099</span></a>] [<a href="/pubmed/16602102" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 16602102</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="cdsp.REF.magoulas.2012.68">Magoulas PL, El-Hattab AW. Systemic primary carnitine deficiency: an overview of clinical manifestations, diagnosis, and management. <span><span class="ref-journal">Orphanet J Rare Dis. </span>2012;<span class="ref-vol">7</span>:68.</span> [<a href="/pmc/articles/PMC3495906/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC3495906</span></a>] [<a href="/pubmed/22989098" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 22989098</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="cdsp.REF.rose.2012.118">Rose EC, di San Filippo CA, Ndukwe Erlingsson UC, Ardon O, Pasquali M, Longo N. Genotype-phenotype correlation in primary carnitine deficiency. <span><span class="ref-journal">Hum Mutat. </span>2012;<span class="ref-vol">33</span>:118–23.</span> [<a href="/pmc/articles/PMC3240685/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC3240685</span></a>] [<a href="/pubmed/21922592" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 21922592</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="cdsp.REF.rasmussen.2014.215">Rasmussen J, Nielsen OW, Janzen N, Duno M, Gislason H, K&#x000f8;ber L, Steuerwald U, Lund AM. Carnitine levels in 26,462 individuals from the nationwide screening program for primary carnitine deficiency in the Faroe Islands. <span><span class="ref-journal">J Inherit Metab Dis. </span>2014;<span class="ref-vol">37</span>:215–22.</span> [<a href="/pubmed/23653224" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 23653224</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="cdsp.REF.schimmenti.2007.441">Schimmenti LA, Crombez EA, Schwahn BC, Heese BA, Wood TC, Schroer RJ, Bentler K, Cederbaum S, Sarafoglou K, McCann M, Rinaldo P, Matern D, di San Filippo CA, Pasquali M, Berry SA, Longo N. Expanded newborn screening identifies maternal primary carnitine deficiency. <span><span class="ref-journal">Mol Genet Metab. </span>2007;<span class="ref-vol">90</span>:441–5.</span> [<a href="/pubmed/17126586" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 17126586</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="cdsp.REF.spiekerkoetter.2003.613">Spiekerkoetter U, Huener G, Baykal T, Demirkol M, Duran M, Wanders R, Nezu J, Mayatepek E. Silent and symptomatic primary carnitine deficiency within the same family due to identical mutations in the organic cation/carnitine transporter OCTN2. <span><span class="ref-journal">J Inherit Metab Dis. </span>2003;<span class="ref-vol">26</span>:613–5.</span> [<a href="/pubmed/14605509" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 14605509</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="cdsp.REF.wang.2001.387">Wang Y, Korman SH, Ye J, Gargus JJ, Gutman A, Taroni F, Garavaglia B, Longo N. Phenotype and genotype variation in primary carnitine deficiency. <span><span class="ref-journal">Genet Med. </span>2001;<span class="ref-vol">3</span>:387–92.</span> [<a href="/pubmed/11715001" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 11715001</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="cdsp.REF.wilcken.2003.2304">Wilcken B, Wiley V, Hammond J, Carpenter K. Screening newborns for inborn errors of metabolism by tandem mass spectrometry. <span><span class="ref-journal">N Engl J Med. </span>2003;<span class="ref-vol">348</span>:2304–12.</span> [<a href="/pubmed/12788994" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 12788994</span></a>]</div></li></ul></div></div><div id="cdsp.Chapter_Notes"><h2 id="_cdsp_Chapter_Notes_">Chapter Notes</h2><div id="cdsp.Revision_History"><h3>Revision History</h3><ul><li class="half_rhythm"><div>3 November 2016 (sw) Comprehensive update posted live</div></li><li class="half_rhythm"><div>26 June 2014 (me) Comprehensive update posted live</div></li><li class="half_rhythm"><div>15 March 2012 (me) Review posted live</div></li><li class="half_rhythm"><div>5 December 2011 (aeh) Original submission</div></li></ul></div></div><div id="bk_toc_contnr"></div></div></div>
            <div class="post-content"><div><div class="half_rhythm"><a href="/books/about/copyright/">Copyright</a> © 1993-2019, University of Washington, Seattle. GeneReviews is
a registered trademark of the University of Washington, Seattle. All rights
reserved.<p class="small">GeneReviews® chapters are owned by the University of Washington. Permission is
hereby granted to reproduce, distribute, and translate copies of content materials for
noncommercial research purposes only, provided that (i) credit for source (<a href="http://www.genereviews.org/" ref="pagearea=meta&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">http://www.genereviews.org/</a>) and copyright (© 1993-2019 University of
Washington) are included with each copy; (ii) a link to the original material is provided
whenever the material is published elsewhere on the Web; and (iii) reproducers,
distributors, and/or translators comply with the <a href="/books/n/gene/GRcopyright_permiss/">GeneReviews® Copyright Notice and Usage
Disclaimer</a>. No further modifications are allowed. For clarity, excerpts
of GeneReviews chapters for use in lab reports and clinic notes are a permitted
use.</p><p class="small">For more information, see the <a href="/books/n/gene/GRcopyright_permiss/">GeneReviews® Copyright Notice and Usage
Disclaimer</a>.</p><p class="small">For questions regarding permissions or whether a specified use is allowed,
contact: <a href="mailto:dev@null" data-email="ude.wu@tssamda" class="oemail">ude.wu@tssamda</a>.</p></div><div class="small"><span class="label">Bookshelf ID: NBK84551</span><span class="label">PMID: <a href="/pubmed/22420015" title="PubMed record of this page" ref="pagearea=meta&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">22420015</a></span></div><div style="margin-top:2em" class="bk_noprnt"><a class="bk_cntns" href="/books/n/gene/">GeneReviews by Title</a><div class="pagination bk_noprnt"><a class="active page_link prev" href="/books/n/gene/iiae3/" title="Previous page in this title">&lt; Prev</a><a class="active page_link next" href="/books/n/gene/tango2-mea/" title="Next page in this title">Next &gt;</a></div></div></div></div>
            
        </div>

        <!-- Custom content below content -->
        <div class="col4">
            
        </div>
        
        
        <!-- Book content -->
        
        <!-- Custom contetnt below bottom nav -->
        <div class="col5">
            
        </div>
    </div>

    <div id="rightcolumn" class="four_col col last">
        <!-- Custom content above discovery portlets -->
        <div class="col6">
            <div id="ncbi_share_book"><a href="#" class="ncbi_share" data-ncbi_share_config="popup:false,shorten:true" ref="id=NBK84551&amp;db=books">Share</a></div>

        </div>
        <div xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Views</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="PDF_download" id="Shutter"></a></div><div class="portlet_content"><ul xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="simple-list"><li><a href="/books/NBK84551/?report=reader">PubReader</a></li><li><a href="/books/NBK84551/?report=printable">Print View</a></li><li><a data-jig="ncbidialog" href="#_ncbi_dlg_citbx_NBK84551" data-jigconfig="width:400,modal:true">Cite this Page</a><div id="_ncbi_dlg_citbx_NBK84551" style="display:none" title="Cite this Page"><div class="bk_tt">El-Hattab AW. Systemic Primary Carnitine Deficiency. 2012 Mar 15 [Updated 2016 Nov 3]. In: Adam MP, Ardinger HH, Pagon RA, et al., editors. GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle; 1993-2019. <span class="bk_cite_avail"></span></div></div></li><li><a href="/books/NBK84551/pdf/Bookshelf_NBK84551.pdf">PDF version of this page</a> (170K)</li><li><a href="#" class="toggle-glossary-link" title="Enable/disable links to the glossary">Disable Glossary Links</a></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>In this GeneReview</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="page-toc" id="Shutter"></a></div><div class="portlet_content"><ul xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="simple-list"><li><a href="#cdsp.Summary" ref="log$=inpage&amp;link_id=inpage">Summary</a></li><li><a href="#cdsp.Diagnosis" ref="log$=inpage&amp;link_id=inpage">Diagnosis</a></li><li><a href="#cdsp.Clinical_Characteristics" ref="log$=inpage&amp;link_id=inpage">Clinical Characteristics</a></li><li><a href="#cdsp.Genetically_Related_Allelic_Disorde" ref="log$=inpage&amp;link_id=inpage">Genetically Related (Allelic) Disorders</a></li><li><a href="#cdsp.Differential_Diagnosis" ref="log$=inpage&amp;link_id=inpage">Differential Diagnosis</a></li><li><a href="#cdsp.Management" ref="log$=inpage&amp;link_id=inpage">Management</a></li><li><a href="#cdsp.Genetic_Counseling" ref="log$=inpage&amp;link_id=inpage">Genetic Counseling</a></li><li><a href="#cdsp.Resources" ref="log$=inpage&amp;link_id=inpage">Resources</a></li><li><a href="#cdsp.Molecular_Genetics" ref="log$=inpage&amp;link_id=inpage">Molecular Genetics</a></li><li><a href="#cdsp.References" ref="log$=inpage&amp;link_id=inpage">References</a></li><li><a href="#cdsp.Chapter_Notes" ref="log$=inpage&amp;link_id=inpage">Chapter Notes</a></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>GeneReviews Links</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="source-links" id="Shutter"></a></div><div class="portlet_content"><ul xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="simple-list"><li><a href="/books/n/gene/advanced/"><i>GeneReviews</i> Advanced Search</a></li><li><a href="/books/n/gene/glossary/"><i>GeneReviews</i> Glossary</a></li><li><a href="/books/n/gene/resource_mats/">Resource Materials</a> <span class="bk_hlight1">NEW FEATURE</span></li><li><a href="/books/n/gene/updates/">New in <i>GeneReviews</i></a></li><li><a href="/books/n/gene/authors/">Author List</a></li><li><a href="/books/n/gene/prospective_authors/">For Current/Prospective Authors</a></li><li><a href="/books/n/gene/GRpersonnel/"><i>GeneReviews</i> Personnel</a></li><li><a href="/books/n/gene/howto_linkin/">Download/Link to <i>GeneReviews</i></a></li><li><a href="/books/n/gene/contact_us/">Contact Us</a></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Tests in GTR by Gene</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="document-links" id="Shutter"></a></div><div class="portlet_content"><ul xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="simple-list"><li><a href="https://www.ncbi.nlm.nih.gov/gtr/tests/?term=6584[geneid]" ref="pagearea=document-links&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri&amp;link_id=tests_in_gtr_by_gene">SLC22A5</a></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Related information</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="discovery_db_links" id="Shutter"></a></div><div class="portlet_content"><ul><li class="brieflinkpopper"><a class="brieflinkpopperctrl" href="/books/?Db=omim&amp;DbFrom=books&amp;Cmd=Link&amp;LinkName=books_omim&amp;IdsFromResult=2869936" ref="log$=recordlinks">OMIM</a><div class="brieflinkpop offscreen_noflow">Related OMIM records</div></li><li class="brieflinkpopper"><a class="brieflinkpopperctrl" href="/books/?Db=pmc&amp;DbFrom=books&amp;Cmd=Link&amp;LinkName=books_pmc_refs&amp;IdsFromResult=2869936" ref="log$=recordlinks">PMC</a><div class="brieflinkpop offscreen_noflow">PubMed Central citations</div></li><li class="brieflinkpopper"><a class="brieflinkpopperctrl" href="/books/?Db=pubmed&amp;DbFrom=books&amp;Cmd=Link&amp;LinkName=books_pubmed_refs&amp;IdsFromResult=2869936" ref="log$=recordlinks">PubMed</a><div class="brieflinkpop offscreen_noflow">Links to PubMed</div></li><li class="brieflinkpopper"><a class="brieflinkpopperctrl" href="/books/?Db=gene&amp;DbFrom=books&amp;Cmd=Link&amp;LinkName=books_gene&amp;IdsFromResult=2869936" ref="log$=recordlinks">Gene</a><div class="brieflinkpop offscreen_noflow">Locus Links</div></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Similar articles in PubMed</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="PBooksDiscovery_RA" id="Shutter"></a></div><div class="portlet_content"><ul><li class="brieflinkpopper two_line"><a class="brieflinkpopperctrl" href="/pubmed/22989098" ref="ordinalpos=1&amp;linkpos=1&amp;log$=relatedreviews&amp;logdbfrom=pubmed"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Systemic primary carnitine deficiency: an overview of clinical manifestations, diagnosis, and management.</a><span class="source">[Orphanet J Rare Dis. 2012]</span><div class="brieflinkpop offscreen_noflow"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Systemic primary carnitine deficiency: an overview of clinical manifestations, diagnosis, and management.<div class="brieflinkpopdesc"><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Magoulas PL, El-Hattab AW. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">Orphanet J Rare Dis. 2012 Sep 18; 7:68. Epub 2012 Sep 18.</em></div></div></li><li class="brieflinkpopper two_line"><a class="brieflinkpopperctrl" href="/pubmed/20301700" ref="ordinalpos=1&amp;linkpos=2&amp;log$=relatedreviews&amp;logdbfrom=pubmed"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Carnitine Palmitoyltransferase 1A Deficiency</a><span class="source">[GeneReviews<sup>®</sup>. 1993]</span><div class="brieflinkpop offscreen_noflow"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Carnitine Palmitoyltransferase 1A Deficiency<div class="brieflinkpopdesc"><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Bennett MJ, Santani AB. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">GeneReviews®. 1993</em></div></div></li><li class="brieflinkpopper two_line"><a class="brieflinkpopperctrl" href="/pubmed/22593918" ref="ordinalpos=1&amp;linkpos=3&amp;log$=relatedreviews&amp;logdbfrom=pubmed"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Propionic Acidemia</a><span class="source">[GeneReviews<sup>®</sup>. 1993]</span><div class="brieflinkpop offscreen_noflow"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Propionic Acidemia<div class="brieflinkpopdesc"><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Shchelochkov OA, Carrillo N, Venditti C. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">GeneReviews®. 1993</em></div></div></li><li class="brieflinkpopper two_line"><a class="brieflinkpopperctrl" href="/pubmed/20301631" ref="ordinalpos=1&amp;linkpos=4&amp;log$=relatedreviews&amp;logdbfrom=pubmed"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Citrullinemia Type I</a><span class="source">[GeneReviews<sup>®</sup>. 1993]</span><div class="brieflinkpop offscreen_noflow"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Citrullinemia Type I<div class="brieflinkpopdesc"><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Quinonez SC, Thoene JG. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">GeneReviews®. 1993</em></div></div></li><li class="brieflinkpopper two_line"><a class="brieflinkpopperctrl" href="/pubmed/20301788" ref="ordinalpos=1&amp;linkpos=5&amp;log$=relatedreviews&amp;logdbfrom=pubmed"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Glycogen Storage Disease Type III</a><span class="source">[GeneReviews<sup>®</sup>. 1993]</span><div class="brieflinkpop offscreen_noflow"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Glycogen Storage Disease Type III<div class="brieflinkpopdesc"><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Dagli A, Sentner CP, Weinstein DA. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">GeneReviews®. 1993</em></div></div></li></ul><a class="seemore" href="/sites/entrez?db=pubmed&amp;cmd=link&amp;linkname=pubmed_pubmed_reviews&amp;uid=22420015" ref="ordinalpos=1&amp;log$=relatedreviews_seeall&amp;logdbfrom=pubmed">See reviews...</a><a class="seemore" href="/sites/entrez?db=pubmed&amp;cmd=link&amp;linkname=pubmed_pubmed&amp;uid=22420015" ref="ordinalpos=1&amp;log$=relatedarticles_seeall&amp;logdbfrom=pubmed">See all...</a></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Recent Activity</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="recent_activity" id="Shutter"></a></div><div class="portlet_content"><div xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" id="HTDisplay" class=""><div class="action"><a href="javascript:historyDisplayState('ClearHT')">Clear</a><a href="javascript:historyDisplayState('HTOff')" class="HTOn">Turn Off</a><a href="javascript:historyDisplayState('HTOn')" class="HTOff">Turn On</a></div><ul id="activity"><li class="ra_rcd ralinkpopper two_line"><a class="htb ralinkpopperctrl" ref="log$=activity&amp;linkpos=1" href="/portal/utils/pageresolver.fcgi?recordid=5dfc954775f66d18aa1b5b99">Systemic Primary Carnitine Deficiency - GeneReviews®</a><div class="ralinkpop offscreen_noflow">Systemic Primary Carnitine Deficiency - GeneReviews®<div class="brieflinkpopdesc"></div></div><div class="tertiary"></div></li></ul><p class="HTOn">Your browsing activity is empty.</p><p class="HTOff">Activity recording is turned off.</p><p id="turnOn" class="HTOff"><a href="javascript:historyDisplayState('HTOn')">Turn recording back on</a></p><a class="seemore" href="/sites/myncbi/recentactivity">See more...</a></div></div></div>
        
        <!-- Custom content below discovery portlets -->
        <div class="col7">
            
        </div>
    </div>
</div>

<!-- Custom content after all -->
<div class="col8">
    
</div>
<div class="col9">
    
</div>

<script type="text/javascript" src="/corehtml/pmc/js/jquery.scrollTo-1.4.2.js"></script>
<script type="text/javascript">
    (function($){
        $('.skiplink').each(function(i, item){
            var href = $($(item).attr('href'));
            href.attr('tabindex', '-1').addClass('skiptarget'); // ensure the target can receive focus
            $(item).on('click', function(event){
                event.preventDefault();
                $.scrollTo(href, 0, {
                    onAfter: function(){
                        href.focus();
                    }
                });
            });
        });
    })(jQuery);
</script>
                        </div>
                        <div class="bottom">
                            
                            <div id="NCBIFooter_dynamic">
    <a id="help-desk-link" class="help_desk" href="" target="_blank">Support Center</a>
    <a id="help-desk-link" class="help_desk" href="https://support.ncbi.nlm.nih.gov/ics/support/KBList.asp?Time=2019-12-20T04:32:56-05:00&amp;Snapshot=%2Fprojects%2Fbooks%2FPBooks@5.22&amp;Host=portal103&amp;ncbi_phid=CE8AD569DFC876A10000000006D30389&amp;ncbi_session=CE8AD569DFC95461_1747SID&amp;from=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fbooks%2FNBK84551%2F&amp;Db=pmc&amp;folderID=134&amp;Ncbi_App=bookshelf&amp;Page=literature&amp;style=classic&amp;deptID=28049" target="_blank">Support Center</a>
    
</div>

                            <div class="footer" id="footer">
    
    <div class="subfooter"> </div><script type="text/javascript" src="/portal/portal3rc.fcgi/static/js/preloaderWidget.js"> </script>
    <div id="external-disclaimer" class="offscreen_noflow">
        External link. Please review our <a href="https://www.nlm.nih.gov/privacy.html">privacy policy</a>.
    </div>    
    <div id="ncbifooter" class="contact_info">      
        <div id="footer-contents-right">
            <div id="nlm_thumb_logo">
                <a href="https://www.nlm.nih.gov" title="NLM">NLM</a>
            </div>
            <div id="nih_thumb_logo">
                <a href="https://www.nih.gov" title="NIH">NIH</a>
            </div>
            <div id="hhs_thumb_logo">
                <a href="https://www.hhs.gov" title="DHHS">DHHS</a>
            </div>
            <div id="usagov_thumb_logo">
                <a href="https://www.usa.gov" title="USA.gov">USA.gov</a>
            </div>         
        </div>
        
        <div id="footer-contents-left">
            <p class="address vcard">
                <span class="url">
                    <a class="fn url newdomain" href="https://www.ncbi.nlm.nih.gov">National Center for
                        Biotechnology Information</a>,
                </span> <span class="org url newdomain"><a href="https://www.nlm.nih.gov/">U.S. National Library of Medicine</a></span>
                <span class="adr">
                    <span class="street-address">8600 Rockville Pike</span>, <span class="locality">Bethesda</span>
                    <span class="region">MD</span>, <span class="postal-code">20894</span>
                    <span class="country-name">USA</span>
                </span>
            </p>
            
            <a href="/home/about/policies.shtml">Policies and Guidelines</a> | <a href="/home/about/contact.shtml">Contact</a>
        </div>
    </div>
    <script type="text/javascript" src="/portal/portal3rc.fcgi/rlib/js/InstrumentOmnitureBaseJS/InstrumentNCBIConfigJS/InstrumentNCBIBaseJS/InstrumentPageStarterJS.js?v=1"> </script>    
    <script type="text/javascript" src="/portal/portal3rc.fcgi/static/js/hfjs2.js"> </script>
</div>
                        </div>
                    </div>
                    <!--/.page-->
                </div>
                <!--/.wrap-->
            </div><!-- /.twelve_col -->
        </div>
        <!-- /.grid -->

        <span class="PAFAppResources"></span>
        
        <!-- BESelector tab -->
        
        
        
        <noscript><img alt="statistics" src="/stat?jsdisabled=true&amp;ncbi_db=books&amp;ncbi_pdid=book-part&amp;ncbi_acc=NBK84551&amp;ncbi_domain=gene&amp;ncbi_report=record&amp;ncbi_type=fulltext&amp;ncbi_objectid=&amp;ncbi_pcid=/NBK84551/&amp;ncbi_pagename=Systemic Primary Carnitine Deficiency - GeneReviews® - NCBI Bookshelf&amp;ncbi_bookparttype=chapter&amp;ncbi_app=bookshelf" /></noscript>
        
        
        <!-- usually for JS scripts at page bottom -->
        <!--<component id="PageFixtures" label="styles"></component>-->
    

<!-- CE8AD569DFC95461_1747SID /projects/books/PBooks@5.22 portal103 v4.1.r585844 Mon, May 06 2019 02:53:16 -->

<script type="text/javascript" src="//static.pubmed.gov/portal/portal3rc.fcgi/4176521/js/3879255/4121861/3501987/4008961/3893018/3821238/4062932/4123007/4087685/4076480/3921943/3400083/3426610.js" snapshot="books"></script></body>
</html>